Compare the effectiveness of betamethasone and lavender and peppermint in reducing the severity of symptoms in patients with eczema and psoriasis

Phase 2

Recruiting

• Conditions: L40.9, L85; Condition 1: eczema and psoriasis. Condition 2: Psoriasis.; Dry skin dermatitis, Psoriasis, unspecified

• Registration Number: IRCT20100420003760N4
• Lead Sponsor: Khoram-Abad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

The study population of men and women over the age of 10 with eczema or psoriasis who have been referred to the nomadic hospital since the beginning of the fall of 2016 for one year.

Exclusion Criteria

Patients who have had a corticosteroid injection or have taken other oral or topical medications will be excluded.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Scaly. Timepoint: 0,7,14. Method of measurement: Questionnaire.;Painful. Timepoint: 0,7,14. Method of measurement: Questionnaire.;Itching. Timepoint: 0,7,14. Method of measurement: Questionnaire.;Skin lesions. Timepoint: 0,7,14. Method of measurement: Questionnaire.;Swelling. Timepoint: 0,7,14. Method of measurement: Questionnaire.;Redness of the skin. Timepoint: 0,7,14. Method of measurement: Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Skin irritation. Timepoint: Days 1,7,14. Method of measurement: Questionnaire.